Related Experiment Video
Updated: Aug 23, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses
Barbara Seliger1, Rudolf Lichtenfels, Roland Kellner
1Third Department of Internal Medicine at the Johannes Gutenberg University, Mainz, Germany. 3-med.klinik.uni-mainz.de
Abstract:
Proteome analysis has rapidly developed in the post-genome era and is now widely accepted as the complementary technology for genetic profiling. It has been shown to be a powerful tool for studying human diseases and for identifying novel prognostic, diagnostic and therapeutic markers. This review focuses on the identification of new biomarkers and therapeutic targets for renal cell carcinoma using different 'ome'-based technologies.

